封面
市场调查报告书
商品编码
1842257

全球生命科学领域下一代客户参与平台市场:市场规模、份额和趋势分析(按组件、部署方式、功能、最终用途和地区划分),细分市场预测(2025-2033 年)

Life Sciences Next-generation Customer Engagement Platforms Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment Mode, By Functionality, By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

面向生命科学领域的下一代客户参与平台:市场概览

全球生命科学下一代客户参与平台市场预计在 2024 年达到 23.7 亿美元,预计到 2033 年将达到 55.6 亿美元,2025 年至 2033 年的复合年增长率为 10.13%。

医疗服务提供者越来越注重个人化护理,需要先进的互动平台来协调互动并改善患者治疗效果。

医疗保健专业人员和患者对客製化互动的需求日益增长,推动了先进客户互动平台 (CEP) 解决方案的开发和应用。以病人为中心的医疗模式的转变,加速了生命科学领域对新一代客户参与平台的需求。企业需要超越产品促销的数位化工具,以提供持续的支持、教育和以结果为导向的互动。例如:

2024年10月,Temedica和罗氏扩大了双方成功的伙伴关係,透过Retinora(用于视网膜疾病)和Brisa(用于多发性硬化症)等数位辅助应用程序,惠及数万名患者。这些应用程式基于Temedica的平台构建,并整合了真实世界证据,提供个人化支持,从而改善患者照护,未来还将推出更多此类应用程式。

2022年3月,DarioHealth与赛诺菲美国公司达成一项价值3,000万美元的多年策略协议,旨在加速Dario数位疗法平台的商业性化应用,并拓展其数位健康解决方案。此次合作将促销,扩大其在医疗保险计划和雇主市场的分销管道,并共同开发新的解决方案以改善慢性病管理。

2021 年 9 月,基因泰克(罗氏)部署了 LifeLink Systems 的人工智慧聊天机器人,以改善临床试验中的患者沟通,直接推动了 CEP 的采用,表明需要一个能够以可扩展和合规的方式全天候管理患者接触点的平台。

这些案例表明,该行业正在将以患者为中心的理念融入其互动策略中。数位伴侣、人工智慧聊天机器人和数位疗法的日益融合,正促使生命科学公司采用先进的客户参与平台,这些平台能够整合这些工具,支持合规的互动,并在整个医疗生态系统中创造可衡量的价值,最终推动市场成长。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业机会分析
    • 产业挑战分析
    • 案例研究
  • 商业环境分析
    • 波特五力分析
    • PESTLE分析

第四章:生命科学领域下一代客户参与平台(CEP)市场:按组件分類的估算与趋势分析

  • 组件专属仪錶板
  • 按组件分類的市场份额和波动分析(2024 年和 2033 年)
  • 按组件分類的市场规模预测和趋势分析(2021-2033)
  • 软体
  • 服务(实施、整合、支援)

第五章:生命科学领域下一代客户参与平台(CEP)市场:按部署方式分類的估算与趋势分析

  • 部署仪表板
  • 按部署方式分類的市场份额和波动分析(2024 年和 2033 年)
  • 按部署方式分類的市场规模预测与趋势分析(2021-2033)
  • 云端/SaaS(多租户、订阅)
  • 本地部署

第六章:生命科学领域下一代客户参与平台(CEP)市场:按功能分類的估算与趋势分析

  • 功能仪錶板
  • 按功能分類的市场份额和波动分析(2024 年和 2033 年)
  • 按功能分類的市场规模预测和趋势分析(2021-2033)
  • 核心参与层
    • 端对端内容管理
    • 优化互动管道
    • 商业学习与培训
  • 进阶软体功能
    • 认知能力
    • 职能角色范围

第七章:生命科学领域下一代客户参与平台(CEP)市场:按最终用途分類的估算和趋势分析

  • 终端用户仪錶板
  • 依最终用途分類的市占率及变化分析(2024 年及 2033 年)
  • 按最终用途分類的市场规模预测和趋势分析(2021-2033 年)
  • 製药公司
  • 生技公司
  • 医疗设备公司
  • CRO(委外研发机构)
  • 其他(包括研究机构)

第八章:生命科学领域下一代客户参与平台(CEP)市场:按地区分類的估算和趋势分析

  • 市场概览:按地区
  • 各区域市场要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 参与企业概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Aktana, Inc
    • IQVIA(OCE)
    • Veeva Systems
    • Exeevo
    • Pitcher
    • Salesforce
    • ACTO Technologies Inc.
    • Allego
    • Bigtincan
    • ODAIA Intelligence Inc.
    • Qstream, Inc.
    • Seismic
    • Tellius
    • Viseven
    • Vodori
    • WhizAI
    • ZS Associates
    • Okra
    • P360
    • Quantified.ai
    • verbTEAMS
Product Code: GVR-4-68040-729-3

Life Sciences Next-generation Customer Engagement Platforms Market Summary

The global life sciences next-generation customer engagement platformsmarket size was estimated at USD 2.37 billion in 2024 and is projected to reach USD 5.56 billion by 2033, growing at a CAGR of 10.13% from 2025 to 2033. Healthcare providers increasingly focus on personalized care, necessitating advanced engagement platforms to tailor interactions and enhance patient outcomes.

Growing need for customized interactions with healthcare professionals and patients, driving the development and implementation of advanced CEP solutions. The shift toward patient-centric care is accelerating demand for life sciences next-generation customer engagement platforms, as companies need digital tools that go beyond product promotion to deliver continuous support, education, and outcomes-focused engagement. For instance:

In October 2024, Temedica and Roche extended their successful partnership, benefiting tens of thousands of patients with digital companion apps like Retinora for retinal diseases and Brisa for multiple sclerosis. These apps, built on Temedica's platform and integrated with real-world evidence, provide personalized support that improves patient care, with ongoing expansions planned.

In March 2022, DarioHealth entered into a multi-year, USD 30 million strategic agreement with Sanofi U.S. to accelerate the commercial adoption of Dario's digital therapeutics platform and expand digital health solutions. The collaboration aims to promote Dario's multi-condition digital therapeutics, increase sales reach in health plan and employer markets, and jointly develop new solutions to improve chronic disease management.

In September 2021, Genentech (Roche) deployed Lifelink Systems' AI-powered chatbot to improve patient communication in clinical trials. This demonstrated the need for platforms that can manage 24/7, scalable, and compliant patient touchpoints, which directly fuels CEP adoption.

These instances demonstrate how the industry is incorporating patient-centered approaches into engagement strategies. As digital companions, AI chatbots, and digital therapeutics collaborations grow, life sciences companies are compelled to adopt advanced customer engagement platforms that integrate these tools, support compliant interactions, and deliver measurable value across the care ecosystem, ultimately fueling market growth.

Global Life Sciences Next-generation Customer Engagement Platforms Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global life sciences next-generation customer engagement platforms market report based on component, deployment mode, functionality, end use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services (implementation, integration, support)
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud / SaaS (multi-tenant, subscription)
  • On-premise
  • Functionality Outlook (Revenue, USD Million, 2021 - 2033)
  • Core Engagement Layers
    • End to end content management
    • Engagement channel optimization
    • Commercial learning and training
  • Advanced Software Capabilities
    • Cognitive Capabilities
    • Functional Role Coverage
    • Sales
    • Marketing
    • Medical Affairs
    • Market Access
    • Patient Services
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Medical Device Firms
  • Others (Including Research Institutes, etc.)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Component
    • 1.2.2. Deployment Mode
    • 1.2.3. Functionality
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Shift toward patient-centered care
      • 3.2.1.2. Adoption of digital transformation in healthcare
      • 3.2.1.3. Demand for personalized customer engagement
      • 3.2.1.4. Integration of AI and machine learning
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Implementation Costs
      • 3.2.2.2. Data Privacy and Regulatory Compliance
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Component Estimates & Trend Analysis

  • 4.1. Component Segment Dashboard
  • 4.2. Component Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services (implementation, integration, support)
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Deployment Estimates & Trend Analysis

  • 5.1. Deployment Segment Dashboard
  • 5.2. Deployment Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Deployment, 2021 to 2033 (USD Million)
  • 5.4. Cloud / SaaS (multi-tenant, subscription)
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Functionality Type Estimates & Trend Analysis

  • 6.1. Functionality Type Dashboard
  • 6.2. Functionality Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
  • 6.4. Core Engagement Layers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. End to end content management
      • 6.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Engagement channel optimization
      • 6.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Commercial learning and training
      • 6.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Advanced Software Capabilities
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Cognitive Capabilities
      • 6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Functional Role Coverage
      • 6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.2. Sales
        • 6.5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.3. Marketing
        • 6.5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.4. Medical Affairs
        • 6.5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.5. Market Access
        • 6.5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.6. Patient Services
        • 6.5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2024 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical Companies
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Biotechnology Companies
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Medical Device Firms
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Contract Research Organizations (CROs)
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others (Including Research Institutes, etc.)
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market: Key Takeaways
  • 8.3. North America
    • 8.3.1. North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamic
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive insights
      • 8.3.2.4. U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamic
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive insights
      • 8.3.3.4. Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamic
      • 8.3.4.2. Regulatory framework
      • 8.3.4.3. Competitive insights
      • 8.3.4.4. Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamic
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive insights
      • 8.4.2.4. Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key country dynamic
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive insights
      • 8.4.3.4. UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamic
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive insights
      • 8.4.4.4. France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamic
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive insights
      • 8.4.5.4. Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamic
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive insights
      • 8.4.6.4. Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamic
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive insights
      • 8.4.7.4. Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamic
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive insights
      • 8.4.8.4. Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamic
      • 8.4.9.2. Regulatory framework
      • 8.4.9.3. Competitive insights
      • 8.4.9.4. Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamic
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive insights
      • 8.5.2.4. Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamic
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive insights
      • 8.5.3.4. China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamic
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive insights
      • 8.5.4.4. India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamic
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive insights
      • 8.5.5.4. South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamic
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive insights
      • 8.5.6.4. Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamic
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive insights
      • 8.5.7.4. Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamic
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive insights
      • 8.6.2.4. Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamic
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive insights
      • 8.6.3.4. Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamic
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive insights
      • 8.7.2.4. South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamic
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive insights
      • 8.7.3.4. Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamic
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive insights
      • 8.7.4.4. UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamic
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive insights
      • 8.7.5.4. Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Aktana, Inc
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. IQVIA (OCE)
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Veeva Systems
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Exeevo
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Pitcher
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Salesforce
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. ACTO Technologies Inc.
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Allego
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Bigtincan
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. ODAIA Intelligence Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Qstream, Inc.
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Seismic
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Tellius
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Viseven
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Vodori
      • 9.5.15.1. Overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. WhizAI
      • 9.5.16.1. Overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. ZS Associates
      • 9.5.17.1. Overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Okra
      • 9.5.18.1. Overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product benchmarking
      • 9.5.18.4. Strategic initiatives
    • 9.5.19. P360
      • 9.5.19.1. Overview
      • 9.5.19.2. Financial performance
      • 9.5.19.3. Product benchmarking
      • 9.5.19.4. Strategic initiatives
    • 9.5.20. Quantified.ai
      • 9.5.20.1. Overview
      • 9.5.20.2. Financial performance
      • 9.5.20.3. Product benchmarking
      • 9.5.20.4. Strategic initiatives
    • 9.5.21. verbTEAMS
      • 9.5.21.1. Overview
      • 9.5.21.2. Financial performance
      • 9.5.21.3. Product benchmarking
      • 9.5.21.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 6 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 7 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 10 U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 11 U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 14 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 15 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 18 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 19 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 22 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 23 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 24 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 26 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 27 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 28 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 29 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 30 UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 31 UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 32 UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 33 UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 34 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 35 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 36 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 37 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 39 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 40 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 41 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 43 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 44 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 45 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 47 Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 48 Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 49 Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 51 Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 52 Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 53 Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 55 Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 56 Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 57 Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by country, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 63 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 64 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 65 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 66 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 68 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 69 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 70 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 71 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 72 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 73 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 74 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 76 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 77 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 78 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 80 Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 81 Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 82 Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 84 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 85 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 86 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by country, 2021 - 2033 (USD Million)
  • Table 88 Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 89 Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 90 Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 91 Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 93 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 94 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 95 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 97 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 98 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 99 Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 100 MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by country, 2021 - 2033 (USD Million)
  • Table 101 MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 102 MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 103 MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 104 MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 105 South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 106 South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 107 South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 108 South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 113 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 114 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 115 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 116 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by component, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by functionality, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Life Sciences Next-generation Customer Engagement Platforms: Market outlook
  • Fig. 5 Life Sciences Next-generation Customer Engagement Platforms: Segment outlook
  • Fig. 6 Life Sciences Next-generation Customer Engagement Platforms: Competitive landscape outlook
  • Fig. 7 Parent Market outlook
  • Fig. 8 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Driver Impact
  • Fig. 9 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Restraint impact
  • Fig. 10 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, Component outlook key takeaways (USD Million)
  • Fig. 11 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Component movement analysis (USD Million)
  • Fig. 12 Software Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Services (implementation, integration, support) Market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, deployment outlook key takeaways (USD Million)
  • Fig. 15 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: deployment movement analysis, (USD Million)
  • Fig. 16 Cloud / SaaS (multi-tenant, subscription) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 On-premise Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, functionality outlook key takeaways (USD Million)
  • Fig. 19 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: functionality movement analysis, (USD Million)
  • Fig. 20 Core Engagement Layers Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 End to end content management Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Engagement channel optimization Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Commercial learning and training Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Advanced Software Capabilities Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Cognitive Capabilities Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Functional Role Coverage Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Sales Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Marketing Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Medical Affairs Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Market Access Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Patient Services Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market, end use outlook key takeaways (USD Million)
  • Fig. 33 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: end use movement analysis (USD Million)
  • Fig. 34 Pharmaceutical Companies Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Biotechnology Companies Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Medical Device Firms Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Contract Research Organizations (CROs) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others (Including Research Institutes, etc) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Total Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Marketplace: Key takeaways
  • Fig. 41 Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Regional outlook, 2024 & 2033
  • Fig. 42 North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 US Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)